Period of time： 2012年6期
Publisher： Adis International
Founded in： 1994
Total resources： 114
ISSN： 1173-8804
Subject： R4 Clinical Medicine
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
BioDrugs,volume 26,issue 6
Menu
Access to resources
Recommend
The US Approach to Biosimilars: The Long-Awaited FDA Approval Pathway
By Calvo Begoña,Zuñiga Leyre in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.By Hagemeister Fredrick B. in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.Cyclin-Dependent Kinase Modulators and Cancer Therapy
By Gallorini Marialucia,Cataldi Amelia,> in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.Therapeutic Potential of Aptamer-siRNA Conjugates for Treatment of HIV-1
By Zhou Jiehua,Rossi John J. in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.siRNA: A New Approach to Target Neuropathic Pain
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.Belatacept: In Adult Kidney Transplant Recipients
By Garnock-Jones Karly P. in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.A/H5N1 Prepandemic Influenza Vaccine (Vepacel®): A Guide to Its Use
By Keating Gillian M.,Plosker Greg L.,Lyseng-Williamson Katherine A. in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.Vandetanib: A Guide to Its Use in Advanced Medullary Thyroid Cancer
By Keating Gillian M.,Lyseng-Williamson Katherine A.,Frampton James E. in (2012)
BioDrugs,volume 26,issue 6 , Vol. 26, Iss. 6, 2012-12 , pp.